Synthetic progress and anti-leukemic research on indirubin analogues: a review since 2010.

RSC Adv · 2025 · PMC12705230 · PMID 41403675

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Summary and discussion of the structure–activity relationship Based on the existing indirubin derivatives and their anti-proliferative activity results against leukemia, a highly significant structure–activity relationship (SAR) analysis was performed.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.